Boston Scientific
(NYSE) BSX
Boston Scientific Financials at a Glance
Market Cap
$75.00B
Revenue (TTM)
$20.62B
Net Income (TTM)
$3.55B
EPS (TTM)
$2.38
P/E Ratio
21.16
Dividend
$0.00
Beta (Volatility)
0.69 (Low)
Dividend
$0.00
Beta (Volatility)
0.69 (Low)
Price
$50.36
Volume
85,921.623
Open
$53.13
Price
$50.36
Volume
85,921.623
Open
$53.13
Previous Close
$50.46
Daily Range
$50.04 - $53.20
52-Week Range
$50.04 - $109.50
Dividend
$0.00
Beta (Volatility)
0.69 (Low)
Price
$50.36
Volume
85,921.623
Open
$53.13
Previous Close
$50.46
Daily Range
$50.04 - $53.20
52-Week Range
$50.04 - $109.50
BSX News
BSX: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Boston Scientific
Industry
Healthcare Equipment and Supplies
Sector
Health CareEmployees
59,000
CEO
Michael F. Mahoney, MBA
Website
www.bostonscientific.comHeadquarters
Marlborough, MA 01752-1234, US
BSX Financials
Key Financial Metrics (TTM)
Gross Margin
70%
Operating Margin
20%
Net Income Margin
17%
Return on Equity
15%
Return on Capital
10%
Return on Assets
8%
Earnings Yield
4.73%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$75.00B
Shares Outstanding
1.49B
Volume
85.92K
Avg. Volume
17.10M
Financials (TTM)
Gross Profit
$13.85B
Operating Income
$3.97B
EBITDA
$3.73B
Operating Cash Flow
$4.53B
Capital Expenditure
-$876.00M
Free Cash Flow
$3.66B
Cash & ST Invst.
$2.05B
Total Debt
$12.42B
Boston Scientific Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$5.20B
+11.6%
Gross Profit
$3.61B
+22.5%
Gross Margin
69.44%
N/A
Market Cap
$75.00B
N/A
Market Cap/Employee
$1.42M
N/A
Employees
53,000
N/A
Net Income
$1.34B
+98.4%
EBITDA
$1.07B
-11.9%
Quarterly Fundamentals
Net Cash
-$9.51B
+13.5%
Accounts Receivable
$3.03B
+12.4%
Inventory
$3.12B
+8.7%
Long Term Debt
$10.99B
+0.5%
Short Term Debt
$41.00M
-94.7%
Return on Assets
8.01%
N/A
Return on Invested Capital
10.42%
N/A
Free Cash Flow
$171.00M
-51.7%
Operating Cash Flow
$348.00M
-35.7%